Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 17, 2012

View Archived Issues

GSK develops new RAR-related orphan receptor-gamma modulators

Antigen Discovery's malaria research supported by new SBIR grant

Herbal extract mix efficacious in Alzheimer's disease model

Roche reports novel bradykinin B1 receptor antagonists

Boehringer Ingelheim Pharma patents new prostanoid DP2 receptor antagonists

New potential candidate cognition-enhancing drugs designed

Chinaberry fruit extract shows promise to treat Alzheimer's disease

Investigation yields novel candidate anticancer drugs

New candidate immunotherapies divulged by UCB

Novel complement activation-inhibiting products synthesized

Upsher-Smith Laboratories completes acquisition

Unigene and Nordic Bioscience select preliminary lead compound for type 2 diabetes

Novel silicon-containing compounds display antiallergic activity

Synergy Pharmaceuticals reaches enrollment target in plecanatide trial

Regulus Therapeutics forms microRNA alliance with AstraZeneca

Cortex Pharmaceuticals announces merger

Regulus and Biogen Idec establish biomarker collaboration

FDA clears phase I study of UMK-121

CRT licenses preclinical FAK inhibitor programs

Promising results reported for SNS01-T in multiple myeloma study

Safety monitoring board recommends continuation of PreSERVE-AMI trial

IND filed for APX-001

Lexicon Pharmaceuticals releases topline data on LX-2931 and LX-7101

Pluristem's PLX cells set to enter phase II study in India

FDA places partial clinical hold on Idenix program

Development collaboration begins for TGR-1202

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...